NT5E and neoplasm: These findings support the hypotheses presented in previous sections, namely, that the disorder and reprogramming of purine metabolism are predominantly manifested in tumor cells and fibroblasts, and that NT5E, a PM-disorder gene, indicates a poor prognosis for tumor patients.